Cellerant Therapeutics Overview
- Year Founded
-
2003
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Cellerant Therapeutics General Information
Description
Developer of cellular and antibody therapies designed to treat hematologic malignancies and other blood-related disorders. The company's therapies use a hematopoietic stem cell-based mechanism for the treatment of cancers and autoimmune diseases, enabling physicians to treat multiple myeloma and myelodysplastic syndrome in an enhanced way.
Contact Information
Website
www.cellerant.comCorporate Office
- 39899 Balentine Drive
- Suite 200
- Newark, CA 94560
- United States
Corporate Office
- 39899 Balentine Drive
- Suite 200
- Newark, CA 94560
- United States
Cellerant Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Out of Business | 02-Apr-2024 | Completed | Out of Business | |||
| 14. Later Stage VC | 12-Feb-2019 | Completed | Clinical Trials - Phase 3 | |||
| 13. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 12. Grant | 22-Aug-2017 | Completed | Pre-Clinical Trials | |||
| 11. Debt - General | 01-Feb-2015 | Completed | Pre-Clinical Trials | |||
| 10. Grant | 11-Sep-2014 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 08-Oct-2012 | Completed | Pre-Clinical Trials | |||
| 8. Later Stage VC (Series BB) | 21-Sep-2012 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC (Series BB) | 25-Apr-2011 | $2.02M | $55.5M | Completed | Pre-Clinical Trials | |
| 6. Later Stage VC (Series AA) | 09-Feb-2010 | $9M | $53.5M | Completed | Pre-Clinical Trials |
Cellerant Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series BB | ||||||||
| Series AA |
Cellerant Therapeutics Comparisons
Industry
Financing
Details
Cellerant Therapeutics Competitors (95)
One of Cellerant Therapeutics’s 95 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Cogent Biosciences | Formerly VC-backed | Waltham, MA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Light Chain Bioscience | Formerly PE-Backed | Geneva, Switzerland | ||||
| Aronora | Venture Capital-Backed | Portland, OR |
Cellerant Therapeutics Patents
Cellerant Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021055985-A1 | Ipsc-derived, hypoimmunogenic, myeloid progenitor cells | Inactive | 22-Sep-2019 | ||
| WO-2021055985-A8 | Ipsc-derived, hypoimmunogenic, myeloid progenitor cells | Inactive | 22-Sep-2019 | ||
| WO-2018071910-A2 | Anti-il1-rap antibodies | Inactive | 16-Oct-2016 | ||
| WO-2018071910-A3 | Anti-il1-rap antibodies | Inactive | 16-Oct-2016 | ||
| AU-2017343565-A1 | Isoquinolidinobenzodiazepine (iqb)-1(chloromethyl)-2,3-dihydro-1h-benzo[e]indole (cbi) dimers | Inactive | 10-Oct-2016 | A61K31/5513 |
Cellerant Therapeutics Signals
Cellerant Therapeutics FAQs
-
When was Cellerant Therapeutics founded?
Cellerant Therapeutics was founded in 2003.
-
Where is Cellerant Therapeutics headquartered?
Cellerant Therapeutics is headquartered in Newark, CA.
-
What is the size of Cellerant Therapeutics?
Cellerant Therapeutics has 4 total employees.
-
What industry is Cellerant Therapeutics in?
Cellerant Therapeutics’s primary industry is Drug Discovery.
-
Is Cellerant Therapeutics a private or public company?
Cellerant Therapeutics is a Private company.
-
What is Cellerant Therapeutics’s current revenue?
The current revenue for Cellerant Therapeutics is .
-
How much funding has Cellerant Therapeutics raised over time?
Cellerant Therapeutics has raised $74.4M.
-
Who are Cellerant Therapeutics’s competitors?
Centrose, Cogent Biosciences, Inovio Pharmaceuticals, Light Chain Bioscience, and Aronora are some of the 95 competitors of Cellerant Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process